CIGB-300 (P15-Tat)
Anti-CK2 cyclic cell-penetrating research peptide.
Oncology Research Peptides
123B9 is a synthetic 11-amino-acid tumor-homing peptide with an N-terminal 3-chloro-4-fluorophenoxyacetic-acid modification and a C-terminal amide. It is studied as a selective EphA2-receptor research ligand for targeted drug-delivery and peptide-drug-conjugate (PDC) development research, with reported metabolic-stability advantages over earlier progenitor peptides, and is investigated across pancreatic, melanoma, breast, and prostate tumor-model research.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Anti-CK2 cyclic cell-penetrating research peptide.
Telomerase-derived 16-mer research peptide.
PSP-94-derived antitumor research peptide.